These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1098 related articles for article (PubMed ID: 20864679)

  • 1. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.
    Lee S; Varvel NH; Konerth ME; Xu G; Cardona AE; Ransohoff RM; Lamb BT
    Am J Pathol; 2010 Nov; 177(5):2549-62. PubMed ID: 20864679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis.
    Liu Z; Condello C; Schain A; Harb R; Grutzendler J
    J Neurosci; 2010 Dec; 30(50):17091-101. PubMed ID: 21159979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.
    Hickman SE; Allison EK; Coleman U; Kingery-Gallagher ND; El Khoury J
    Front Immunol; 2019; 10():2780. PubMed ID: 31849963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway.
    Lee S; Xu G; Jay TR; Bhatta S; Kim KW; Jung S; Landreth GE; Ransohoff RM; Lamb BT
    J Neurosci; 2014 Sep; 34(37):12538-46. PubMed ID: 25209291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease.
    Cho SH; Sun B; Zhou Y; Kauppinen TM; Halabisky B; Wes P; Ransohoff RM; Gan L
    J Biol Chem; 2011 Sep; 286(37):32713-22. PubMed ID: 21771791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease.
    Fuhrmann M; Bittner T; Jung CK; Burgold S; Page RM; Mitteregger G; Haass C; LaFerla FM; Kretzschmar H; Herms J
    Nat Neurosci; 2010 Apr; 13(4):411-3. PubMed ID: 20305648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial phagocytosis and activation underlying photoreceptor degeneration is regulated by CX3CL1-CX3CR1 signaling in a mouse model of retinitis pigmentosa.
    Zabel MK; Zhao L; Zhang Y; Gonzalez SR; Ma W; Wang X; Fariss RN; Wong WT
    Glia; 2016 Sep; 64(9):1479-91. PubMed ID: 27314452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of CX3CR1 haplodeficiency in male and female APP
    Hemonnot-Girard AL; Valverde AJ; Hua J; Delaygue C; Linck N; Maurice T; Rassendren F; Hirbec H
    Brain Behav Immun; 2021 Jan; 91():404-417. PubMed ID: 33190798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease.
    Puntambekar SS; Moutinho M; Lin PB; Jadhav V; Tumbleson-Brink D; Balaji A; Benito MA; Xu G; Oblak A; Lasagna-Reeves CA; Landreth GE; Lamb BT
    Mol Neurodegener; 2022 Jun; 17(1):47. PubMed ID: 35764973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial Cx3cr1 knockout reduces prion disease incubation time in mice.
    Grizenkova J; Akhtar S; Brandner S; Collinge J; Lloyd SE
    BMC Neurosci; 2014 Mar; 15():44. PubMed ID: 24655482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease.
    Song M; Jin J; Lim JE; Kou J; Pattanayak A; Rehman JA; Kim HD; Tahara K; Lalonde R; Fukuchi K
    J Neuroinflammation; 2011 Aug; 8():92. PubMed ID: 21827663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MyD88 deficiency ameliorates β-amyloidosis in an animal model of Alzheimer's disease.
    Lim JE; Kou J; Song M; Pattanayak A; Jin J; Lalonde R; Fukuchi K
    Am J Pathol; 2011 Sep; 179(3):1095-103. PubMed ID: 21763676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity.
    Dworzak J; Renvoisé B; Habchi J; Yates EV; Combadière C; Knowles TP; Dobson CM; Blackstone C; Paulsen O; Murphy PM
    PLoS One; 2015; 10(6):e0127730. PubMed ID: 26038823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Term Effects of Microglia-Specific Mitochondrial Dysfunction on Amyloidosis in Transgenic Models of Alzheimer's Disease.
    Steffen J; Stenzel J; Ibrahim S; Pahnke J
    J Alzheimers Dis; 2018; 65(2):465-474. PubMed ID: 30040730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
    Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
    Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial CX3CR1 production increases in Alzheimer's disease and is regulated by noradrenaline.
    González-Prieto M; Gutiérrez IL; García-Bueno B; Caso JR; Leza JC; Ortega-Hernández A; Gómez-Garre D; Madrigal JLM
    Glia; 2021 Jan; 69(1):73-90. PubMed ID: 32662924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease.
    Cameron B; Tse W; Lamb R; Li X; Lamb BT; Landreth GE
    J Neurosci; 2012 Oct; 32(43):15112-23. PubMed ID: 23100432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
    Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
    J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.